161 related articles for article (PubMed ID: 26311051)
1. Association of the functional BCL-2 rs2279115 genetic variant and small cell lung cancer.
Yang X; Gao F; Ma F; Ren Y; Chen H; Liang X; Han S; Xiong X; Pan W; Zhou C; Zhou L; Yang M
Tumour Biol; 2016 Feb; 37(2):1693-8. PubMed ID: 26311051
[TBL] [Abstract][Full Text] [Related]
2. Functional BCL-2 regulatory genetic variants contribute to susceptibility of esophageal squamous cell carcinoma.
Pan W; Yang J; Wei J; Chen H; Ge Y; Zhang J; Wang Z; Zhou C; Yuan Q; Zhou L; Yang M
Sci Rep; 2015 Jul; 5():11833. PubMed ID: 26132559
[TBL] [Abstract][Full Text] [Related]
3. Functional BCL-2 rs2279115 Promoter Noncoding Variant Contributes to Glioma Predisposition, Especially in Males.
Qiu XG; Chen YD; Yuan J; Zhang N; Lei T; Liu J; Yang M
DNA Cell Biol; 2019 Jan; 38(1):85-90. PubMed ID: 30481055
[TBL] [Abstract][Full Text] [Related]
4. A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer.
Gao F; Xiong X; Pan W; Yang X; Zhou C; Yuan Q; Zhou L; Yang M
PLoS One; 2015; 10(8):e0135647. PubMed ID: 26274820
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in BCL2 3'-UTR was associated with lung cancer risk and prognosis in male Chinese population.
Xu P; Liu L; Wang J; Zhang K; Hong X; Deng Q; Xiang J; Zhang X; He M; Wu T; Guo H
PLoS One; 2013; 8(8):e72197. PubMed ID: 23977251
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of Bcl-2 promoter in cancer susceptibility and prognosis: a meta-analysis.
Yao Z; Yang B; Liu Z; Li W; He Q; Peng X
Oncotarget; 2017 Apr; 8(15):25270-25278. PubMed ID: 28445963
[TBL] [Abstract][Full Text] [Related]
7. TNFSF15 promoter polymorphisms increase the susceptibility to small cell lung cancer: a case-control study.
Gao H; Niu Z; Zhang Z; Wu H; Xie Y; Yang Z; Li A; Jia Z; Zhang X
BMC Med Genet; 2019 Feb; 20(1):29. PubMed ID: 30736740
[TBL] [Abstract][Full Text] [Related]
8. Association of genetic polymorphism of BCL-2 (rs2279115) with susceptibility to HCV-related hepatocellular carcinoma.
Ahmed HS; Wahab EA; Elhady HA; Elgerby MM
Immunol Res; 2020 Aug; 68(4):189-197. PubMed ID: 32623689
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the apoptotic pathway gene BCL-2 and survival in small cell lung cancer.
Knoefel LF; Werle-Schneider G; Dally H; Müller PJ; Edler L; Bartsch H; Tuengerthal S; Heussel CP; Reinmuth N; Thomas M; Risch A
J Thorac Oncol; 2011 Jan; 6(1):183-9. PubMed ID: 21107291
[TBL] [Abstract][Full Text] [Related]
10. Association of the CHRNA3 locus with lung cancer risk and prognosis in Chinese Han population.
Niu X; Chen Z; Shen S; Liu Y; Zhou D; Zhang J; Li Z; Yu Y; Liao M; Lu S; He L
J Thorac Oncol; 2010 May; 5(5):658-66. PubMed ID: 20234319
[TBL] [Abstract][Full Text] [Related]
11. Functional role of CyclinD1 polymorphism (G870A) in modifying susceptibility and overall survival of North Indian lung cancer patients.
Pandey A; Bahl C; Sharma S; Singh N; Behera D
Tumori; 2018 Jun; 104(3):179-187. PubMed ID: 30086699
[TBL] [Abstract][Full Text] [Related]
12. Association of BCL2-938C>A genetic polymorphism with glioma risk in Chinese Han population.
Li W; Qian C; Wang L; Teng H; Zhang L
Tumour Biol; 2014 Mar; 35(3):2259-64. PubMed ID: 24287948
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic markers in the BCL-2 family of apoptosis-related genes with endometrial cancer risk in a Chinese population.
Dorjgochoo T; Xiang YB; Long J; Shi J; Deming S; Xu WH; Cai H; Cheng J; Cai Q; Zheng W; Shu XO
PLoS One; 2013; 8(4):e60915. PubMed ID: 23637776
[TBL] [Abstract][Full Text] [Related]
14. The Impact of
Zhuo M; Zhuang X; Tang W; Xu J; Zhang C; Qian X; Wang J; Liu H; Liu Y; Chen Z; Lin H
Biomed Res Int; 2018; 2018():8305745. PubMed ID: 30671474
[TBL] [Abstract][Full Text] [Related]
15. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese.
Tian T; Shu Y; Chen J; Hu Z; Xu L; Jin G; Liang J; Liu P; Zhou X; Miao R; Ma H; Chen Y; Shen H
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1183-7. PubMed ID: 19293314
[TBL] [Abstract][Full Text] [Related]
16. Role of Bcl-2 -938 C>A polymorphism in susceptibility and prognosis of cancer: a meta-analysis.
Zhang X; Weng W; Xu W; Wang Y; Yu W; Tang X; Ma L; Pan Q; Wang J; Sun F
Sci Rep; 2014 Nov; 4():7241. PubMed ID: 25430556
[TBL] [Abstract][Full Text] [Related]
17. Association of PSMA4 polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a Chinese Han population.
Wang T; Chen T; Thakur A; Liang Y; Gao L; Zhang S; Tian Y; Jin T; Liu JJ; Chen M
Clin Transl Oncol; 2015 Jul; 17(7):564-9. PubMed ID: 25744645
[TBL] [Abstract][Full Text] [Related]
18. Association between insulin-like growth factor binding protein-3 promoter polymorphism of -1590 C>A and lung cancer susceptibility in a Chinese Han population.
Dai X; Liu Z; Ren J; Wu G
Genet Test Mol Biomarkers; 2011 May; 15(5):301-6. PubMed ID: 21254935
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic variants of the CASP3, CASP9, BCL-2 and NKX3-1 genes as candidate markers for prostate cancer susceptibility and poor prognosis.
de Souza MR; de Souza MF; de Nóbrega M; Cilião HL; Dos Reis MB; Fuganti PE; Cólus IMS
Mol Biol Rep; 2022 Sep; 49(9):9079-9087. PubMed ID: 35708863
[TBL] [Abstract][Full Text] [Related]
20. Correlation Between BCL2 and Mcl1 Single Nucleotide Polymorphisms and Chemotherapy Response in Jordanian Patients with Colorectal Cancer.
Mhaidat NM; Amawi H; Alzoubi KH
Curr Pharm Biotechnol; 2021; 22(5):646-653. PubMed ID: 32619164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
